Delivery Order SPE2DR25D1103-SPE2DR26FE408
- Not listed
- The Defense Logistics Agency awarded a $30,851.70 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $27,876.13 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,053.06 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $8,590.31 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count unit), a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency awarded a $14,288.03 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is due for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $50,724.85 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, which is not set-aside designated, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency issued a delivery order valued at $8,234.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 (a combination inhalation powder for chronic obstructive pulmonary disease treatment) on December 2, 2025, with an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency awarded a $23,626.87 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This competitively awarded, firm fixed-price contract has an ultimate completion date of December 18, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,375.39 on May 27, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-dose units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, representing a single pharmaceutical delivery to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $14,351.01 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE408Delivery Order
The Defense Logistics Agency awarded a $4,036.34 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-dose units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company was competitively selected to deliver this respiratory medication, which is a maintenance treatment for chronic obstructive pulmonary disease. As a child contract under the larger SPE2DX Indefinite Delivery Contract, this delivery order demonstrates AmerisourceBergen's ongoing capability to fulfill federal medical supply requirements through the DLA's established pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 12/15/25 |